Findings of Misconduct in Science, 45427 [E7-15881]

Download as PDF Federal Register / Vol. 72, No. 156 / Tuesday, August 14, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the President’s Council on Bioethics on September 6– 7, 2007 mstockstill on PROD1PC66 with NOTICES AGENCY: The President’s Council on Bioethics, HHS. ACTION: Notice. SUMMARY: The President’s Council on Bioethics (Edmund D. Pellegrino, MD, Chairman) will hold its thirtieth meeting, at which it will (1) Discuss a projected ‘‘white paper’’ on the neurological standard for the determination of death; (2) continue the exploratory phase of a potential inquiry into the ‘‘crisis’’ of the healing professions with expert presentations and Council discussions; and (3) continue the exploratory phase of a potential inquiry into ethical issues associated with nanotechnology with expert presentations and Council discussions. Subjects discussed at past Council meetings (although not on the agenda for the September 2007 meeting) include: therapeutic and reproductive cloning, assisted reproduction, reproductive genetics, the ethics of health care, neuroscience, aging retardation, organ transplantation, newborn screening, human dignity, personalized medicine, and lifespanextension. Publications issued by the Council to date include: Human Cloning and Human Dignity: An Ethical Inquiry (July 2002); Beyond Therapy: Biotechnolody and the Pursuit of Happiness (October 2003); Being Human: Readings from the President’s Council on Bioethics (December 2003); Monitoring Stem Cell Research (January 2004), Reproduction and Responsibility: The Regulation of New Biotechnologies (March 2004), Alternative Sources of Human Pluripotent Stem Cells: A White Paper (May 2005), and Taking Care: Ethical Caregiving in Our Aging Society (September 2005). Reports on the bioethical significance of the concept of human dignity and on organ procurement, transplantation, and allocation are forthcoming. DATES: The meeting will take place Thursday, September 6, 2007, from 9 am to 5:15 pm, ET; and Friday, September 7, 2007, from 8:30 am to 11:45 am, ET. ADDRESSES: The Carolina Inn, 211 Pittsboro Street, Chapel Hill, NC 27516. Phone 919–933–2001 or 1–800–962– 8519. Agenda: The meeting agenda will be posted at https://www.bioethics.gov. Public Comments: The Council encourages public input, either in person or in writing. At this meeting, VerDate Aug<31>2005 16:35 Aug 13, 2007 Jkt 211001 interested members of the public may address the Council, beginning at 11:30 am, on Friday, September 7. Comments are limited to no more than five minutes per speaker or organization. As a courtesy, please inform Ms. Diane M. Gianelli, Director of Communications, in advance of your intention to make a public statement, and give your name and affiliation. To submit a written statement, mail or e-mail it to Ms. Gianelli at one of the addresses given below. FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of Communications, The President’s Council on Bioethics, 1425 New York Avenue, NW., Suite C100 Washington, DC 20005. Telephone 202/296–4669. Email info@bioethics.gov. Web site: https://www.bioethics.gov. Dated: August 6, 2007. F. Daniel Davis, Executive Director, The President’s Council on Bioethics. [FR Doc. 07–3948 Filed 8–13–07; 8:45 am] BILLING CODE 4154–07–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Misconduct in Science Office of the Secretary, HHS. Notice. AGENCY: ACTION: SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI), the Assistant Secretary for Health, and another Federal agency have taken final action in the following case: Juan Carlos Jorge-Rivera, Ph.D., Dartmouth College: Based on the findings of an inquiry conducted by Dartmouth College, an investigation conducted by another Federal agency, and additional analysis conducted by the Office of Research Integrity (ORI) during its oversight review, the U.S. Public Health Service (PHS) found that Juan Carlos Jorge-Rivera, Ph.D., former postdoctoral fellow, Department of Physiology, Dartmouth College, engaged in misconduct in science in research funded by National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), grant R01 NS28668. Specifically, Dr. Jorge-Rivera knowingly and intentionally falsified amplifier gain in at least eleven (11) experiments of his postdoctoral research aimed at measuring the effects of anabolic steroids on GABAnergic current in brain cells and reported the falsified data in Figures 4 and 6 of the PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 45427 following paper: Jorge-Rivera, J.C., McIntyre, K.L., & Henderson, L.P. ‘‘Anabolic steroids induce region- and subunit-specific modulations of GABA receptor mediated currents in the rat forebrain.’’ Journal of Neurophysiology 83:3299–3309, 2000. Dr. Jorge-Rivera has been debarred by the Federal agency with joint jurisdiction for a period of two (2) years, beginning on January 11, 2007, and ending on January 11, 2009. ORI has implemented the following administrative actions: (1) For a period of three (3) years, beginning on June 23, 2007, and ending on June 22, 2010, Dr. Jorge-Rivera is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) for a period of three (3) years, beginning at the end of his debarment period (January 11, 2009), and ending on January 10, 2012, Dr. Jorge-Rivera must submit, in conjunction with each application for PHS funds, annual reports, manuscripts, or abstracts of PHS-funded research in which he is involved, a certification that the data he provides are based on actual experiments or are otherwise legitimately derived and that the data, procedures, and methodology are accurately reported in the application or report. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E7–15881 Filed 8–13–07; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60 Day–07–0677] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the E:\FR\FM\14AUN1.SGM 14AUN1

Agencies

[Federal Register Volume 72, Number 156 (Tuesday, August 14, 2007)]
[Notices]
[Page 45427]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-15881]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Misconduct in Science

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI), the Assistant Secretary for Health, and another Federal agency 
have taken final action in the following case:
    Juan Carlos Jorge-Rivera, Ph.D., Dartmouth College: Based on the 
findings of an inquiry conducted by Dartmouth College, an investigation 
conducted by another Federal agency, and additional analysis conducted 
by the Office of Research Integrity (ORI) during its oversight review, 
the U.S. Public Health Service (PHS) found that Juan Carlos Jorge-
Rivera, Ph.D., former postdoctoral fellow, Department of Physiology, 
Dartmouth College, engaged in misconduct in science in research funded 
by National Institute of Neurological Disorders and Stroke (NINDS), 
National Institutes of Health (NIH), grant R01 NS28668.
    Specifically, Dr. Jorge-Rivera knowingly and intentionally 
falsified amplifier gain in at least eleven (11) experiments of his 
postdoctoral research aimed at measuring the effects of anabolic 
steroids on GABAnergic current in brain cells and reported the 
falsified data in Figures 4 and 6 of the following paper: Jorge-Rivera, 
J.C., McIntyre, K.L., & Henderson, L.P. ``Anabolic steroids induce 
region- and subunit-specific modulations of GABA receptor mediated 
currents in the rat forebrain.'' Journal of Neurophysiology 83:3299-
3309, 2000.
    Dr. Jorge-Rivera has been debarred by the Federal agency with joint 
jurisdiction for a period of two (2) years, beginning on January 11, 
2007, and ending on January 11, 2009.
    ORI has implemented the following administrative actions:
    (1) For a period of three (3) years, beginning on June 23, 2007, 
and ending on June 22, 2010, Dr. Jorge-Rivera is prohibited from 
serving in any advisory capacity to PHS, including but not limited to 
service on any PHS advisory committee, board, and/or peer review 
committee, or as a consultant; and
    (2) for a period of three (3) years, beginning at the end of his 
debarment period (January 11, 2009), and ending on January 10, 2012, 
Dr. Jorge-Rivera must submit, in conjunction with each application for 
PHS funds, annual reports, manuscripts, or abstracts of PHS-funded 
research in which he is involved, a certification that the data he 
provides are based on actual experiments or are otherwise legitimately 
derived and that the data, procedures, and methodology are accurately 
reported in the application or report.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
 [FR Doc. E7-15881 Filed 8-13-07; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.